Afeletecan

Star0

DB33804ExperimentalSmall molecule

Afeletecan: Overview.

Formula / weight: C₄₅H₄₉N₇O₁₁S · 895.99 g/mol (avg)

Resolves to

Compound

UNIIIX0QAD6RD2CAS215604-75-4ChEMBLCHEMBL2105857ChEBI751653PubChem9941008

Structure

InChIKeySLOJCSGNHWIKIG-JNYZSSQASA-NSMILES

CC[C@@]1(OC(=O)[C@@H](NC(=O)[C@H](CC2=CNC=N2)NC(=S)NC2=CC=C(O[C@H]3O[C@@H](C)[C@@H](O)[C@@H](OC)[C@@H]3O)C=C2)C(C)C)C(=O)OCC2=C1C=C1N(CC3=CC4=CC=CC=C4N=C13)C2=O

Targets

P11387TOP1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Afeletecan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account